A Prospective, Randomized, Double-Blind Study to Compare Two Doses of Recombinant Human Chorionic Gonadotropin in Inducing Final Oocyte Maturity and the Hormonal Profile during the Luteal Phase | Zendy

Carina Chi Wai Chan | Zendy; Ernest Hung Yu Ng | Zendy; William S.B. Yeung | Zendy; Estella Yee Lan Lau | Zendy; PC Ho | Zendy

Open Access

A Prospective, Randomized, Double-Blind Study to Compare Two Doses of Recombinant Human Chorionic Gonadotropin in Inducing Final Oocyte Maturity and the Hormonal Profile during the Luteal Phase

Author(s) -

Carina Chi Wai Chan,

Ernest Hung Yu Ng,

William S.B. Yeung,

Estella Yee Lan Lau,

PC Ho

Publication year - 2005

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2004-2169

Subject(s) - human chorionic gonadotropin , oocyte , luteal phase , andrology , context (archaeology) , in vitro fertilisation , gonadotropin , human fertilization , medicine , endocrinology , gynecology , biology , hormone , pregnancy , embryo , microbiology and biotechnology , anatomy , genetics , paleontology

Different doses of human chorionic gonadotropin (hCG) have been used in various in vitro fertilization (IVF) treatment protocols to achieve final oocyte maturation. There is as yet no agreement on the optimum dose required.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research